Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rob van Os"'
Publikováno v:
Cancers, Vol 11, Iss 6, p 782 (2019)
Purpose: Combining reirradiation (reRT) with hyperthermia (HT) has shown to be of high therapeutic value for patients with loco-regionally recurrent breast cancer. The purpose of this study was to compare the long-term therapeutic effect and toxicity
Externí odkaz:
https://doaj.org/article/89042e8dfa34490db0026e71668619e0
Autor:
Edith Dieleman, Lisa van der Woude, Rob van Os, Liselotte van Bockel, Ida Coremans, Corine van Es, Katrien De Jaeger, Hans Peter Knol, Willemijn Kolff, Frederike Koppe, Jacqueline Pomp, Bart Reymen, Dominic Schinagl, Femke Spoelstra, Caroline Tissing-Tan, Noelle van der Voort van Zyp, Antoinet van der Wel, Robin Wijsman, Michel Dielwart, Erwin Wiegman, Ronald Damhuis, Jose Belderbos
Publikováno v:
Clinical Lung Cancer, 24, 2, pp. 130-136
Clinical Lung Cancer, 24, 130-136
Clinical lung cancer, 24(2), 130-136. CIG MEDIA GROUP, LP
Clinical Lung Cancer, 24(2), 130-136. CIG Media Group, L.P.
Clinical lung cancer. Elsevier
Clinical Lung Cancer, 24, 130-136
Clinical lung cancer, 24(2), 130-136. CIG MEDIA GROUP, LP
Clinical Lung Cancer, 24(2), 130-136. CIG Media Group, L.P.
Clinical lung cancer. Elsevier
In this national lung cancer audit of inoperable NSCLC patients, acute toxicity and 3-month mortality of curative chemoradiation was analyzed. Another important question was whether concurrent chemoradiation for elderly stage III NSCLC patients is sa
Autor:
Daphne Schouten, Rob van Os, Anneke M. Westermann, Hans Crezee, Geertjan van Tienhoven, M. Willemijn Kolff, Adriaan D. Bins
Publikováno v:
Acta Oncologica, 61(4), 441-448. Informa Healthcare
Background: In patients with inoperable local regional recurrences of breast cancer in previously irradiated areas, local control is difficult to maintain and treatment options are limited. The Dutch standard treatment for such recurrences is reirrad
Publikováno v:
Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
Autor:
Oppedijk V; Vera Oppedijk, Rob van Os, Dick J. Richel, Mark I. van Berge Henegouwen, and Maarten C.C.M. Hulshof, Academic Medical Center, Amsterdam; Patty H. Spruit, Vrije Universiteit Medical Center, Amsterdam; Ate van der Gaast, Jan J.B. van Lanschot, Pieter van Hagen, and Caroline M. van Rij, Erasmus Medical Center, Rotterdam; Maurice J. van der Sangen, Catharina Hospital, Eindhoven; Jannet C. Beukema, University Medical Center, Groningen; Heidi Rütten, Radboud University Medical Center, Nijmegen; and Janny G. Reinders, Arnhems Radiotherapeutisch Instituut, Arnhem, the Netherlands., van der Gaast A, van Lanschot JJ, van Hagen P, van Os R, van Rij CM, van der Sangen MJ, Beukema JC, Rütten H, Spruit PH, Reinders JG, Richel DJ, van Berge Henegouwen MI, Hulshof MC
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2014 Feb 10; Vol. 32 (5), pp. 385-91. Date of Electronic Publication: 2014 Jan 13.